Mirae Asset Global Etfs Holdings Ltd. Pmv Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 21,151 shares of PMVP stock, worth $37,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,151Holding current value
$37,014% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PMVP
# of Institutions
97Shares Held
43.7MCall Options Held
500Put Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$11.3 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.91 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.74 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.6 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$4.1 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $79.8M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...